Home › Idiopathic Thrombocytopenic Purpura › Missouri
Idiopathic Thrombocytopenic Purpura clinical trials in Missouri
3 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in Missouri.
Cities in Missouri
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
- University Health Kansas City, Kansas City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07421167A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- MidAmerica Cancer Center, Kansas City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- MidAmerica Cancer Center, Kansas City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.